HIGH GRADE B-CELL LYMPHOMA WITH MYC AND BCL6 REARRANGEMENTS

Clinical trials for HIGH GRADE B-CELL LYMPHOMA WITH MYC AND BCL6 REARRANGEMENTS explained in plain language.

Never miss a new study

Get alerted when new HIGH GRADE B-CELL LYMPHOMA WITH MYC AND BCL6 REARRANGEMENTS trials appear

Sign up with your email to follow new studies for HIGH GRADE B-CELL LYMPHOMA WITH MYC AND BCL6 REARRANGEMENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New 5-Drug attack on Tough-to-Treat blood cancers

Disease control Recruiting now

This study is testing a combination of five medications (called ViPOR) for people with aggressive types of B-cell lymphoma that have returned after treatment or did not respond to prior therapy. The goal is to see if this drug combination can effectively control the cancer and le…

Matched conditions: HIGH GRADE B-CELL LYMPHOMA WITH MYC AND BCL6 REARRANGEMENTS

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC

HIGH GRADE B-CELL LYMPHOMA WITH MYC AND BCL6 REARRANGEMENTS

Get alerted when new HIGH GRADE B-CELL LYMPHOMA WITH MYC AND BCL6 REARRANGEMENTS trials appear

New 5-Drug attack on Tough-to-Treat blood cancers